English   Castellano   Català
Dr. Marco Pugliese
Dr. Manuel J Rodríguez
Prof. Nicole Mahy

Dr. Marco Pugliese
(Founder and Chief Executive Officer, CEO)

Bachelor in Veterinary in 1994. PhD in Neuroscience from the University of Barcelona in 2005 with works focused on analyzing the similarities and differences of the dog as an alternative model of Alzheimer's disease. In 2007 he won the Research Award "Illera Martín" of the Spanish Royal Academy of Veterinary Sciences with a paper related to cognitive dysfunction in aging dogs. In 2006, he creates Neurotec Pharma together with two professor of the University of Barcelona and since 2008 is CEO of the company. Dr Pugliese is co-inventor of the patents related to Neurotec projects and he is author of 13 international publications in the field of neuroscience.

 

Dr. Manuel J Rodríguez
(Founder and Scientific Consultant)

Dr Rodríguez got his degree in Biology in 1995 and obtained a PhD in Molecular Pathology in 2000. Then he made three post-doctoral stays at the School of Medicine of the University of Barcelona and the Dept of Pharmacology of the UCL in London. From 2007, Dr Rodríguez is Professor of Biochemistry and Molecular Biology at the School of Medicine of the University of Barcelona.

His scientific interest has always aimed to understand the cellular and molecular mechanisms underlying neurological disorders such as hypoxic-ischemic injury, multiple sclerosis, Alzheimer's disease and lateral amyotrophic sclerosis.

In 2006, as a consequence of this research, Dr Rodriguez co-founded Neurotec Pharma SL to develop new diagnostic tools and treatments for central nervous system (CNS) diseases. His current research is centred in the molecular relationship between the neuroinflammation and the neurogenesis processes present during adult brain injury.

 

Prof. Nicole Mahy
(Founder and Scientific Consultant)

Prof. Dr Mahy obtained her degree in Pharmacy and a Master in Business Administration in 1973 at the University of Caen (France). She moved to Barcelona and obtained her PhD in Neuroscience in 1979, and started teaching at the Faculty of Medicine of the University of Barcelona (Spain), where she founded in 1982 the Neurochemistry Research group.

She continued leading this group until working on the cellular and molecular mechanisms involved in neurodegenerative diseases. She is member of national and international Evaluation Committees of Research and Education projects. As a visiting professor she developed research projects at Penn University (Philadelphia, USA), Centre de Neurochimie of the CNRS Strasbourg, Laboratoire de Neurobiologie Cellulaire et Fonctionnelle (Marseille, France), Università Cattolica del Sacro Cuore (Roma, Italy) and the Karolinska Institute (Stockholm, Sweden). As a recognition of her trajectory, she received the title of Chevalier de l'Ordre du Mérite of the French Republic in 1998. She co-founded Neurotec Pharma in 2006.